Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular News and Features for 2016

Shelley Wood

December 29, 2016

News Conference News TCT 2016

Are Full, Formal Guidelines Still Useful in the Rapidly Changing TAVR Field?

Todd Neale

October 30, 2016

News Conference News ESC 2016

New Cardio-Oncology Position Statement Reviews Cardiovascular Side Effects of Cancer Therapies and Calls for Further Study

Shelley Wood

August 27, 2016

News Daily News

Fatal Cardiac Events No Higher With Aromatase Inhibitors for Breast Cancer Therapy

L.A. McKeown

April 21, 2016

News Daily News

Anthracycline-Based Chemotherapy Linked to Valve Disease, Even in Absence of Radiation

L.A. McKeown

February 16, 2016

News Daily News

Many Childhood Cancer Survivors Have Silent Cardiac Conditions

Yael L. Maxwell

January 06, 2016

News Daily News

Low-Flow, Low-Gradient Patients More Likely to Die, Less Likely to Undergo AVR

L.A. McKeown

December 07, 2015

News Conference News VEITH 2015

Controversial Intravascular Therapy for Multiple Sclerosis Moves from Cath Lab to the OR

L.A. McKeown

November 24, 2015

News Daily News

Mechanical Circulatory Support in TAVR Tied to Worse Outcomes, Higher Costs

Todd Neale

September 17, 2015

News Conference News ESC 2015

NSAIDs Plus Anticoagulants a Bad Combination

Caitlin E. Cox

September 01, 2015

News Industry News

Boston Scientific Announces CE Mark And FDA Clearance For Safari2 ™ Pre-Shaped Guidewire

July 22, 2015

News Daily News

Acute MI Arising From Coronary Embolism Rare, Often Tied to A-fib

L.A. McKeown

July 08, 2015

News Industry News

One-Year Outcomes Data on Stroke Prevention in Patients With Newly Diagnosed Atrial Fibrillation (AF) to Be Presented at ISTH 2015

June 18, 2015

News Industry News

Patients Undergoing Catheter Ablation Presented at Heart Rhythm 2015

May 15, 2015

Presentation ECHO 2015

Case Studies to Illustrate Pitfalls in Quantification of Valvular Heart Disease

Presenter: Mario J Garcia

April 27, 2015

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2014

Caitlin E. Cox

January 12, 2015

Presentation ESC 2013

Apixaban versus Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Findings from the ARISTOTLE Trial

Presenter: Alvaro Avezum

September 03, 2013

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

Presentation TCT 2012

The RealView Holographic Imaging System for Adult Congenital, Structural, and Valvular Heart Disease

Presenter: Elchanan Bruckheimer

October 22, 2012

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

Advertisement

TCTMD’s Top 10 Most Popular News and Features for 2016

Are Full, Formal Guidelines Still Useful in the Rapidly Changing TAVR Field?

New Cardio-Oncology Position Statement Reviews Cardiovascular Side Effects of Cancer Therapies and Calls for Further Study

Fatal Cardiac Events No Higher With Aromatase Inhibitors for Breast Cancer Therapy

Anthracycline-Based Chemotherapy Linked to Valve Disease, Even in Absence of Radiation

Many Childhood Cancer Survivors Have Silent Cardiac Conditions

Low-Flow, Low-Gradient Patients More Likely to Die, Less Likely to Undergo AVR

Controversial Intravascular Therapy for Multiple Sclerosis Moves from Cath Lab to the OR

Mechanical Circulatory Support in TAVR Tied to Worse Outcomes, Higher Costs

NSAIDs Plus Anticoagulants a Bad Combination

Boston Scientific Announces CE Mark And FDA Clearance For Safari2 ™ Pre-Shaped Guidewire

Acute MI Arising From Coronary Embolism Rare, Often Tied to A-fib

One-Year Outcomes Data on Stroke Prevention in Patients With Newly Diagnosed Atrial Fibrillation (AF) to Be Presented at ISTH 2015

Patients Undergoing Catheter Ablation Presented at Heart Rhythm 2015

Case Studies to Illustrate Pitfalls in Quantification of Valvular Heart Disease

TCTMD’s Top 10 Most Popular News Stories for 2014

Apixaban versus Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Findings from the ARISTOTLE Trial

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

The RealView Holographic Imaging System for Adult Congenital, Structural, and Valvular Heart Disease

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content